Bean, Andrew

Novartis Pharmaceuticals Corporation, East Hanover, NJ;

1 paper on CoChatORCID 0000-0002-4541-9759

Most cited papers

Verified
Phase Ib study of MIW815 (ADU-S100) in combination with spartalizumab (PDR001) in patients (pts) with advanced/metastatic solid tumors or lymphomas.
Meric-Bernstam, F., Sandhu, S. K., Hamid, O., Spreafico, A., Kasper, S., Dummer, R., Shimizu, T., Steeghs, N., Lewis, N., Talluto, C. C., et al. (2019) · Journal of Clinical Oncology
Cancer Immunotherapy and Biomarkersinterferon and immune responses
Cited by 190

Go further with a free account

Verify every reference, keep papers in a library, and ask questions across them.

Sign up - it is free